CRISPR’s Impact on Next Generation Gene Therapies

In 2012, the creation of CRISPR-Cas9 revolutionized gene therapy research by providing a multi-faceted tool for editing genes. Since its invention, there has been a lot of progress in cell and gene therapy development, and it is estimated that the market for these therapies will reach $6.2 billion by 2026. Despite this advancement, there is still much to learn about the full potential of CRISPR and its ability to support the next-generation of gene therapies and for a wider range of diseases.